Investigating the impact of alpha/beta and LETd on relative biological effectiveness in scanned proton beams: An in vitro study based on human cell lines

被引:25
作者
Mara, Elisabeth [1 ,2 ]
Clausen, Monika [1 ]
Khachonkham, Suphalak [1 ,3 ]
Deycmar, Simon [4 ]
Pessy, Clara [1 ]
Doerr, Wolfgang [1 ]
Kuess, Peter [1 ,5 ]
Georg, Dietmar [1 ,5 ]
Gruber, Sylvia [1 ,5 ]
机构
[1] Med Univ Vienna, Dept Radiat Oncol, Christian Doppler Lab Med Radiat Res Radiat Oncol, Vienna, Austria
[2] Univ Appl Sci, Wiener Neustadt, Austria
[3] Mahidol Univ, Dept Diagnost & Therapeut Radiol, Div Radiat Therapy, Fac Med,Ramathibodi Hosp, Bangkok, Thailand
[4] Univ Hosp Zurich, Dept Radiat Oncol, Lab Appl Radiobiol, Zurich, Switzerland
[5] EBG MedAustron GmbH, Wiener Neustadt, Austria
关键词
alpha; ss-ratio; linear energy transfer; pencil beam scanning; proton therapy; RBE modeling; relative biological effectiveness; EFFECTIVENESS RBE VALUES; THERAPY; IRRADIATION; MODEL; MEDULLOBLASTOMA; ASSOCIATIONS; CHALLENGES; PARAMETERS; RADIATION;
D O I
10.1002/mp.14212
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose A relative biological effectiveness (RBE) of 1.1 is commonly used in clinical proton therapy, irrespective of tissue type and depth. This in vitro study was conducted to quantify the RBE of scanned protons as a function of the dose-averaged linear energy transfer (LETd) and the sensitivity factor (alpha/ss)(X). Additionally, three phenomenological models (McNamara, Rorvik, and Jones) and one mechanistic model (repair-misrepair-fixation, RMF) were applied to the experimentally derived data. Methods Four human cell lines (FaDu, HaCat, Du145, SKMel) with differential (alpha/ss)(X) ratios were irradiated in a custom-designed irradiation setup with doses between 0 and 6 Gy at proximal, central, and distal positions of a 80 mm spread-out Bragg peak (SOBP) centered at 80 mm (setup A: proton energies 66.5-135.6 MeV) and 155 mm (setup B: proton energies 127.2-185.9 MeV) depth, respectively. LETd values at the respective cell positions were derived from Monte Carlo simulations performed with the treatment planning system (TPS, RayStation). Dosimetric measurements were conducted to verify dose homogeneity and dose delivery accuracy. RBE values were derived for doses that resulted in 90 % (RBE90) and 10 % (RBE10) of cell survival, and survival after a 0.5 Gy dose (RBE0.5Gy), 2 Gy dose (RBE2Gy), and 6 Gy dose (RBE6Gy). Results LETd values at sample positions were 1.9, 2.1, 2.5, 2.8, 4.1, and 4.5 keV/mu m. For the cell lines with high (alpha/ss)(X) ratios (FaDu, HaCat), the LETd did not impact on the RBE. For low (alpha/ss)(X) cell lines (Du145, SKMel), LQ-derived survival curves indicated a clear correlation of LETd and RBE. RBE90 values up to 2.9 and RBE10 values between 1.4 and 1.8 were obtained. Model-derived RBE predictions slightly overestimated the RBE for the high (alpha/ss)(X) cell lines, although all models except the Jones model provided RBE values within the experimental uncertainty. For low (alpha/ss)(X) cell lines, no agreement was found between experiments and model predictions, that is, all models underestimated the measured RBE. Conclusions The sensitivity parameter (alpha/ss)(X) was observed to be a major influencing factor for the RBE of protons and its sensitivity toward LETd changes. RBE prediction models are applicable for high (alpha/ss)(X) cell lines but do not estimate RBE values with sufficient accuracy in low (alpha/ss)(X) cell lines.
引用
收藏
页码:3691 / 3702
页数:12
相关论文
共 56 条
[1]  
BRITTEN RA, 2012, RADIAT RES, V179, P21
[2]   Calculating Variations in Biological Effectiveness for a 62 MeV Proton Beam [J].
Carante, Mario Pietro ;
Ballarini, Francesca .
FRONTIERS IN ONCOLOGY, 2016, 6
[3]  
Carlino A, 2018, J MED PHYS, V56, P66
[4]   Phantom design and dosimetric characterization for multiple simultaneous cell irradiations with active pencil beam scanning [J].
Clausen, Monika ;
Khachonkham, Suphalak ;
Gruber, Sylvia ;
Kuess, Peter ;
Seemann, Rolf ;
Knaeusl, Barbara ;
Mara, Elisabeth ;
Palmans, Hugo ;
Doerr, Wolfgang ;
Georg, Dietmar .
RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2019, 58 (04) :563-573
[5]   Report of a National Cancer Institute special panel: Characterization of the physical parameters of particle beams for biological research [J].
Durante, Marco ;
Paganetti, Harald ;
Pompos, Arnold ;
Kry, Stephen F. ;
Wu, Xiaodong ;
Grosshans, David R. .
MEDICAL PHYSICS, 2019, 46 (02) :E37-E52
[6]   Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma [J].
El Shafie, Rami A. ;
Czech, Maja ;
Kessel, Kerstin A. ;
Habermehl, Daniel ;
Weber, Dorothea ;
Rieken, Stefan ;
Bougatf, Nina ;
Jaekel, Oliver ;
Debus, Juergen ;
Combs, Stephanie E. .
RADIATION ONCOLOGY, 2018, 13
[7]   Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning [J].
El Shafie, Rami A. ;
Czech, Maja ;
Kessel, Kerstin A. ;
Habermehl, Daniel ;
Weber, Dorothea ;
Rieken, Stefan ;
Bougatf, Nina ;
Jaekel, Oliver ;
Debus, Juergen ;
Combs, Stephanie E. .
RADIATION ONCOLOGY, 2018, 13
[8]   Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury [J].
Giantsoudi, Drosoula ;
Sethi, Roshan V. ;
Yeap, Beow Y. ;
Eaton, Bree R. ;
Ebb, David H. ;
Caruso, Paul A. ;
Rapalino, Otto ;
Chen, Yen-Lin E. ;
Adams, Judith A. ;
Yock, Torunn I. ;
Tarbell, Nancy J. ;
Paganetti, Harald ;
MacDonald, Shannon M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (01) :287-296
[9]   Biological Effects of Passive Versus Active Scanning Proton Beams on Human Lung Epithelial Cells [J].
Gridley, Daila S. ;
Pecaut, Michael J. ;
Mao, Xiao W. ;
Wroe, Andrew J. ;
Luo-Owen, Xian .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2015, 14 (01) :81-98
[10]   Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model [J].
Gupta, Sweta K. ;
Guzman, Elisa A. Torrico ;
Meenach, Samantha A. .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (10) :2143-2153